APA (7th ed.) Citation

Carreiro, S., Loh, C., Kaila, N., Kuo, F., Boiko, S., Ciccone, D. N., . . . Tummino, P. J. Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockade. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Carreiro, Samantha, Christine Loh, Neelu Kaila, Fu-Shan Kuo, Scott Boiko, David N. Ciccone, Joshua J. McElwee, and Peter J. Tummino. Highly Selective HPK1 Inhibitor NDI-101150 Mediates Immune Cell Activation and Robust Antitumor Responses, Distinct from Immune Checkpoint Blockade. BMJ Publishing Group.

MLA (9th ed.) Citation

Carreiro, Samantha, et al. Highly Selective HPK1 Inhibitor NDI-101150 Mediates Immune Cell Activation and Robust Antitumor Responses, Distinct from Immune Checkpoint Blockade. BMJ Publishing Group.